Recerca

Farmacologia molecular i teràpies experimentals

Buscador de publicacions

Publicacions

  • Jaramillo AC, Hubeek I, Broekhuizen R, Pastor-Anglada M, Kaspers GJL, Jansen G, Cloos J and Peters GJ.

    Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.

    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS . 39(10-12): 1379-1388. Nº de cites: 7

    [doi:10.1080/15257770.2020.1746803]

  • Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M.

    FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia

    PHARMACOLOGICAL RESEARCH . 151: 104556-104556. Nº de cites: 5

    [doi:10.1016/j.phrs.2019.104556]

  • Vaskó B, Juhász V, Tóth B, Kurunczi A, Fekete Z, Zolnerciks JK, Kis E, Magnan R, Bidon-Chanal Badia A, Pastor-Anglada M, Hazai E, Bikadi Z, Fülöp F and Krajcsi P.

    Inhibitor selectivity of CNTs and ENTs.

    Xenobiotica . 49(7): 840-851. Nº de cites: 3

    [doi:10.1080/00498254.2018.1501832]

  • Perez-Torras S, Mata-Ventosa A, Drögemöller B, Tarailo-Graovac M, Meijer J, Meinsma R, van Cruchten AG, Kulik W, Viel-Oliva A, Bidon-Chanal A, Ross CJ, Wassermann WW, van Karnebeek CDM, Pastor-Anglada M and van Kuilenburg ABP.

    Deficiency of perforin and hCNT1, a novel inborn error of pyrimidine metabolism, associated with a rapidly developing lethal phenotype due to multi-organ failure

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE . 1865(6): 1182-1191. Nº de cites: 7

    [doi:10.1016/j.bbadis.2019.01.013]

  • Grañe-Boladeras N, Williams D, Tarmakova Z, Stevanovic K, Villani LA, Mehrabi P, Siu KWM, Pastor-Anglada M and Coe IR.

    Oligomerization of equilibrative nucleoside transporters: a novel regulatory and functional mechanism involving PKC and PP1.

    FASEB JOURNAL . 33(3): 3841-3850. Nº de cites: 11

    [doi:10.1096/fj.201800440RR]

  • Pastor-Anglada M, Urtasun N and Perez-Torras S.

    Intestinal Nucleoside Transporters: Function, Expression, and Regulation.

    COMPREHENSIVE PHYSIOLOGY . 8(3): 1003-1017. Nº de cites: 36

    [doi:10.1002/cphy.c170039]

  • Pastor-Anglada M and Perez-Torras S.

    Who Is Who in Adenosine Transport.

    FRONTIERS IN PHARMACOLOGY . 9: 627-627. Nº de cites: 84

    [doi:10.3389/fphar.2018.00627]

  • Pastor-Anglada M and Perez-Torras S.

    Emerging Roles of Nucleoside Transporters.

    FRONTIERS IN PHARMACOLOGY . 9: 606-606. Nº de cites: 108

    [doi:10.3389/fphar.2018.00606]

  • Urtasun N, Boces-Pascual C, Boix L, Bruix J, Pastor-Anglada M and Perez-Torras S.

    Role of drug-dependent transporter modulation on the chemosensitivity of cholangiocarcinoma.

    Oncotarget . 8(52): 90185-90196. Nº de cites: 7

    [doi:10.18632/oncotarget.21624]

  • Arimany-Nardi C, Claudio-Montero A, Viel-Oliva A, Schmidtke P, Estarellas C, Barril X, Bidon-Chanal A and Pastor-Anglada M.

    Identification and Characterization of a Secondary Sodium-Binding Site and the Main Selectivity Determinants in the Human Concentrative Nucleoside Transporter 3.

    MOLECULAR PHARMACEUTICS . 14(6): 1980-1987. Nº de cites: 12

    [doi:10.1021/acs.molpharmaceut.7b00085]